← Back to feed

EDX Medical Group Plc

EDX · AIM · Health Care · mcap £38m today

All announcements

All RNS · 40 Key events · 30

01 Oct 26

Investor Presentation Via Investor Meet Company

CAMBRIDGE, UK: EDX Medical Group plc, which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, is pleased to announce that Professor Sir Chris Evans, Chief Scientific...
RNS 9800299 ↗
17 Sep 26

Employee health contract with Arnold Clark Group

CAMBRIDGE, UK: EDX Medical Group plc, which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, announces the Company has entered into an initial three-year agreement...
RNS 9776211 ↗
04 Sep 26

Director/PDMR shareholdings in the Company Director buys30 % crossed / offer

CAMBRIDGE, UK: EDX Medical Group plc ("EDX Medical", the "Company" or the "Group"), which develops and supplies innovative digital diagnostic products and services for the early detection and treatment of major diseases, has received notification of the...
RNS 9757362 ↗
03 Sep 26

Publication - Annual Report & Financial Statements

CAMBRIDGE, UK: EDX Medical Group, which develops and supplies innovative digital diagnostic products and services to improve early detection and treatment of major diseases, has today published its Annual Report and Financial Statements for the year ending...
RNS 9752863 ↗
27 Aug 26

Scottish Prostate Cancer Initiative update

CAMBRIDGE, UK: EDX Medical Group plc, which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, announces that, as the lead delivery partner in the Scottish Prostate...
RNS 9742184 ↗
24 Aug 26

Equity Fundraising of £2.7 million

CAMBRIDGE, UK: EDX Medical Group plc, which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, announces that it has raised approximately £2.7m through a subscription...
RNS 9735251 ↗
03 Aug 26

Rapid pneumonia test deployed for NHS patients

CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services for major diseases, announces today that the Company and its partners have completed the development and technical validation of a pioneering rapid...
RNS 9699674 ↗
21 Jul 26

Full launch of bowel cancer testing service (BC95)

CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services for major diseases, announces today the full availability of the Company's comprehensive bowel cancer biomarker testing service in the UK.
RNS 9678455 ↗
15 Jul 26

Launch of employee health screening service

CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for major diseases, announces that it is launching a new health and wellbeing screening service in the UK which...
RNS 9668960 ↗
08 Jul 26

EDX Medical service agreement with Astron Health

EDX MEDICAL PROVIDES MOLECULAR PROFILING SERVICE TO ASTRON HEALTH
RNS 9657228 ↗
26 Jun 26

Result of General Meeting

CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer and infectious diseases, today announces the results of its general meeting, held at the Mezzanine...
RNS 9639864 ↗
04 Jun 26

Rule 17 disclosure

CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer and infectious diseases, provides the following update pursuant to Rule 17 and Schedule 2g of the AIM Rules.
RNS 9602858 ↗
04 Jun 26

Expiration of warrants

CAMBRIDGE, UK: EDX Medical Group plc (AIM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, announces the expiration of all warrants over ordinary...
RNS 9600699 ↗
13 May 26

First Day of Dealings on AIM

CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer and infectious diseases, is pleased to announce that the admission of its ordinary shares of £0.01 each...
RNS 9565136 ↗
21 Apr 26

Granting of options over ordinary shares

CAMBRIDGE, UK: EDX Medical Group plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that it...
RNS 9531344 ↗
13 Apr 26

Proposed application for admission to AIM

Proposed application for admission to trading on AIM and proposed withdrawal of Shares from AQSE
RNS 9515724 ↗
25 Mar 26

Scottish Prostate Cancer Initiative

CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announces that the Company is to be the primary delivery partner...
RNS 9490321 ↗
04 Mar 26

Exercise of Warrants

CAMBRIDGE, UK: EDX Medical Group plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, announces that a warrant holder has agreed to...
RNS 9458832 ↗
27 Feb 26

Holding(s) in Company Activist stake

TR-1: Standard form for notification of major holdings
RNS 9451674 ↗
16 Feb 26

Equity Fundraising raises £3.5 million

CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announces that the board of the Company has approved the issue...
RNS 9431369 ↗
09 Jan 26

Director/PDMR Shareholding Director buys30 % crossed / offer

CAMBRIDGE, UK: EDX Medical Group plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that...
RNS 9342876 ↗
08 Jan 26

Director/PDMR Shareholding Director buys

CAMBRIDGE, UK: EDX Medical Group plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that...
RNS 9340140 ↗
06 Jan 26

Director/PDMR Shareholding Director buys

CAMBRIDGE, UK: EDX Medical Group, plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that...
RNS 9334966 ↗
05 Jan 26

Director/PDMR Shareholding Director buys30 % crossed / offerRepeated director buys

CAMBRIDGE, UK: EDX Medical Group, plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that...
RNS 9332331 ↗
02 Jan 26

Director/PDMR Shareholding Director buys30 % crossed / offer

CAMBRIDGE, UK: EDX Medical Group, plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that...
RNS 9328817 ↗
23 Dec 25

Director/PDMR Shareholding Director buys

CAMBRIDGE, UK: EDX Medical Group plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, announces that it was...
RNS 9314228 ↗
19 Dec 25

Half-year Results

Interim report: Six months to 30 September 2025
RNS 9309310 ↗
18 Dec 25

Commercial launch of bowel cancer testing service

COMMERCIAL LAUNCH OF COMPREHENSIVE BOWEL CANCER TESTING SERVICE (BC95)
RNS 9304991 ↗
20 Oct 25

EDX Medical secures up to £4million funding

CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announces that the Company has secured funding totalling up to...
RNS 9180436 ↗
07 Oct 25

Advance testicular cancer testing service launched

OF HIGHLY ACCURATE TC100 TESTICULAR CANCER TESTING SERVICE
RNS 9155737 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.